These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Applications of the xenograft as a model of invasive transitional cell carcinoma of the bladder. Russell PJ; Raghavan D; Philips J; Gregory P Prog Clin Biol Res; 1988; 260():167-81. PubMed ID: 3362878 [TBL] [Abstract][Full Text] [Related]
9. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer. Seraphim LA; Perrapato SD; Slocum HK; Rustum YM; Huben RP J Urol; 1991 Mar; 145(3):613-7. PubMed ID: 1900087 [TBL] [Abstract][Full Text] [Related]
10. [Experimental intravesical treatment of bladder tumor with Concanavalin-A conjugated bleomycin]. Akaza H; Koseki K; Kobayashi K; Niijima T; Soloway MS; Iwabuchi M; Muraoka Y Nihon Hinyokika Gakkai Zasshi; 1984 Feb; 75(2):211-4. PubMed ID: 6205207 [No Abstract] [Full Text] [Related]
11. In vitro drug sensitivity studies in human transitional cell carcinoma of the bladder. Konowalchuk TW; Elhilali M; Mackillop WJ Cancer Lett; 1987 May; 35(2):181-90. PubMed ID: 3107798 [TBL] [Abstract][Full Text] [Related]
12. In vitro chemosensitivity of human bladder cancer. Weisenthal LM; Lalude AO; Miller JB Cancer; 1983 Apr; 51(8):1490-6. PubMed ID: 6186358 [TBL] [Abstract][Full Text] [Related]
13. Treatment of superficial carcinoma of the bladder. Paulson DF Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720 [No Abstract] [Full Text] [Related]
14. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given? Bouffioux C Prog Clin Biol Res; 1985; 185B():47-55. PubMed ID: 4034591 [No Abstract] [Full Text] [Related]
15. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin]. Nogueira March JL; Ojea A; Jamardo D; Figueiredo L Actas Urol Esp; 1984; 8(4):325-8. PubMed ID: 6435407 [No Abstract] [Full Text] [Related]
16. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Huncharek M; McGarry R; Kupelnick B Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841 [TBL] [Abstract][Full Text] [Related]
17. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041 [TBL] [Abstract][Full Text] [Related]
18. Verapamil enhancement of chemotherapeutic efficacy in human bladder cancer cells. Simpson WG; Tseng MT; Anderson KC; Harty JI J Urol; 1984 Sep; 132(3):574-6. PubMed ID: 6433043 [TBL] [Abstract][Full Text] [Related]
19. Transitional explant reduction assay--a new in vitro testing system for intravesical chemotherapy. Weaver DJ; Barrett BA; Ross G; Adelstein EH J Urol; 1986 Feb; 135(2):386-91. PubMed ID: 3080606 [TBL] [Abstract][Full Text] [Related]